Crain’s New York Business – Health Pulse Plus: Oscar launches IPO that could be worth $1.1B AdvantageCare opens Flushing gastroenterology office BioReference, New York Forward partner to offer more rapid tests In assessing Covid-19 vaccination, testing, hospitalization, death and transmission rates, New York came in 49th out of all the states and Washington, D.C., according […]
Search Results for: pay bill
ESPN Chiefs quarterback Patrick Mahomes had his barber tested for COVID-19 to ensure a safe trim. Then he turned to a game of Uno for late-night entertainment. Former Lions QB Matthew Stafford spent a week isolated in a hotel, traveled by private plane to Minneapolis and started a game without taking a single practice snap. […]
The Associated Press NEW YORK (AP) — Gov. Andrew Cuomo extended protections for New Yorkers unable to pay their rent, and New York City Mayor Bill de Blasio set an ambitious goal to test 140,000 people for coronavirus antibodies by early next month. The state’s daily death toll was 231. More on the latest pandemic-related […]
Press Release
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
19
Dec
Dec
ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]
ELMWOOD PARK, Jan. 28, 2019 – BioReference Laboratories Inc., an OPKO Health Company, today announced that they will offer flexible payment arrangements for federal employees affected by the government shutdown. “We recognize the challenging financial position that federal government employees have faced throughout the shutdown,” said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. “While the […]
